<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830631</url>
  </required_header>
  <id_info>
    <org_study_id>B-2004/608-004</org_study_id>
    <nct_id>NCT04830631</nct_id>
  </id_info>
  <brief_title>tDCS Response Prediction Using EEG in Stroke</brief_title>
  <official_title>Prediction of Transcranial Direct Current Stimulation (tDCS) Responses Using Electroencephalography (EEG )in Patients With Chronic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rusk Rehabilitation Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with chronic stroke (&gt;6 months after stroke) having unilateral upper limb&#xD;
      hemiparesis will be recruited. Patients will maintain their usual inpatient rehabilitation&#xD;
      including occupational therapy. At baseline (T0) and after 2weeks of enrollment (T1),&#xD;
      Fugl-Meyer assessment (FMA) will be assessed at each time. And patients with the changes of&#xD;
      FMA between T0 and T1 less than 3 points will be finally recruited. The enrolled patients&#xD;
      will receive additional 30-min cathodal transcranial direct current stimulation (tDCS) over&#xD;
      the contralesional motor cortex for 10 consecutive weekdays, with maintaining their usual&#xD;
      conventional rehabilitation. At T1 and immediately after 10-seessions of tDCS (T2) and 1&#xD;
      month after completing 10-tDCS session (T3), FMA, Actional Research Arm Test (ARAT), Box and&#xD;
      Block Test (BBT) and electroencephalography (EEG) were measured.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in Fugl-Meyer Assesment Score 1</measure>
    <time_frame>Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Fugl-Meyer Assesment Score 2</measure>
    <time_frame>Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Action Research Arm Test Score 1</measure>
    <time_frame>Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Action Research Arm Test Score 2</measure>
    <time_frame>Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Box and Block Test Score 1</measure>
    <time_frame>Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in Box and Block Test Score 2</measure>
    <time_frame>Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in EEG index1</measure>
    <time_frame>Between T1 (before tDCS) and T2 (immediately after completing 10 sessions of tDCS)</time_frame>
    <description>Various kinds of EEG indexe.g., network indexes, event-related dysynchronization, mu suppression) will be surveyed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in EEG index 2</measure>
    <time_frame>Between T2 (immediately after completing 10 sessions of tDCS) and T3 (1 month after completing 10 sessions of tDCS)</time_frame>
    <description>Various kinds of EEG indexe.g., network indexes, event-related dysynchronization, mu suppression) will be surveyed.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Stroke</condition>
  <condition>Rehabilitation</condition>
  <condition>Transcranial Direct Current Stimulation</condition>
  <condition>Motor Recovery</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cathodal transcranial direct current stimulation (tDCS) over the contralesional motor cortex</intervention_name>
    <description>Cathodal tDCS will be applied to the contralesional motor cortex with 2mA intesntisy for 30 mins/day. Total 10 sessions will be applied.</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Chronic stroke patients with unilateral hemiparesis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ranges from 19 to 85 yrs old&#xD;
&#xD;
          -  stroke patients with unilateral hemiparesis&#xD;
&#xD;
          -  1st ever stroke&#xD;
&#xD;
          -  chronic stroke (&gt;6 months after stroke)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  recurrent stroke&#xD;
&#xD;
          -  history of traumatic brain injury&#xD;
&#xD;
          -  Minimental state examination score is 15 or less.&#xD;
&#xD;
          -  Unstable medical conditions&#xD;
&#xD;
          -  Severe delirium, disorders of consciousness&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  can not attach tDCS electrode on the scalp due to skin conditions&#xD;
&#xD;
          -  can not maintain the sitting position&#xD;
&#xD;
          -  intracranial metals&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Won-Seok Kim</last_name>
    <phone>+82317877735</phone>
    <email>wondol77@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Won-Seok Kim</last_name>
      <phone>0317877735</phone>
      <email>wondol77@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Won-Seok Kim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rusk Rehabilitation Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Please Select</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chaiyoung Lim, MD</last_name>
    </contact>
    <investigator>
      <last_name>Chaiyoung Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 31, 2021</study_first_submitted>
  <study_first_submitted_qc>March 31, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>March 31, 2021</last_update_submitted>
  <last_update_submitted_qc>March 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Won-Seok Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>After completing the study, EEG indexes and behavioral outcomes will be considered to be shared with researchers who have the clear and reasonable purpose to use our data.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

